{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:15:06Z","timestamp":1790349306136,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["13\/152\/02"],"award-info":[{"award-number":["13\/152\/02"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Introduction<\/jats:title>\n<jats:p>Renal stones are common, with a lifetime prevalence of 10% in adults. Global incidence is increasing due to increases in obesity and diabetes, with these patient populations being more likely to suffer renal stone disease. Flank pain from stones (renal colic) is the most common cause of emergency admission to UK urology departments. Stones most commonly develop in the lower pole of the kidney (in ~35% of cases) and here are least likely to pass without intervention. Currently there are three technologies available within the UK National Health Service to remove lower pole kidney stones: extracorporeal shockwave lithotripsy (ESWL), percutaneous nephrolithotomy (PCNL) and flexible ureterorenoscopy (FURS) with laser lithotripsy. Current evidence indicates there is uncertainty regarding the management of lower pole stones, and each treatment has advantages and disadvantages. The aim of this trial is to determine the clinical and cost effectiveness of FURS compared with ESWL or PCNL in the treatment of lower pole kidney stones.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The PUrE (PCNL, FURS and ESWL for lower pole kidney stones) trial is a multi-centre, randomised controlled trial (RCT) evaluating FURS versus ESWL or PCNL for lower pole kidney stones. Patients aged \u226516\u2009years with a stone(s) in the lower pole of either kidney confirmed by non-contrast computed tomography of the kidney, ureter and bladder\u00a0(CTKUB) and requiring treatment for a stone \u226410\u2009mm will be randomised to receive FURS or ESWL (RCT1), and those requiring treatment for a stone &gt;10\u2009mm to \u226425\u2009mm will be randomised to receive FURS or PCNL (RCT2). Participants will undergo follow-up by questionnaires every week up to 12\u2009weeks post-intervention and at 12\u2009months post-randomisation. The primary clinical outcome is health status measured by the area under the curve calculated from multiple measurements of the EuroQol five dimensions five-level version (EQ-5D-5L) questionnaire up to 12\u2009weeks post-intervention. The primary economic outcome is the incremental cost per quality-adjusted life year gained at 12\u2009months post-randomisation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Discussion<\/jats:title>\n<jats:p>The PUrE trial aims to provide robust evidence on health status, quality of life, clinical outcomes and resource use to directly inform choice and National Health Service provision of the three treatment options.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Trial registration<\/jats:title>\n<jats:p>ISRCTN: ISRCTN98970319. Registered on 11 November 2015.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13063-020-04326-x","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T12:02:52Z","timestamp":1591272172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The clinical and cost effectiveness of surgical interventions for stones in the lower pole of the kidney: the percutaneous nephrolithotomy, flexible ureterorenoscopy and extracorporeal shockwave lithotripsy for lower pole kidney stones randomised controlled trial (PUrE RCT) protocol"],"prefix":"10.1186","volume":"21","author":[{"given":"Sam","family":"McClinton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Anson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daron","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Turney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"4326_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrurol.2012.253","volume":"10","author":"A Neisius","year":"2013","unstructured":"Neisius A, Preminger GM. Stones in 2012: epidemiology, prevention and redefining therapeutic standards. Nat Rev Urol. 2013;10:75\u20137.","journal-title":"Nat Rev Urol"},{"key":"4326_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/01.ju.0000152082.14384.d7","volume":"173","author":"MS Pearle","year":"2005","unstructured":"Pearle MS, Calhoun EA, Curhan GC, Urologic D. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848\u201357.","journal-title":"J Urol"},{"key":"4326_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1464-410X.2011.10495.x","volume":"109","author":"BW Turney","year":"2012","unstructured":"Turney BW, Reynard JM, Noble JG, Keoghane SR. Trends in urological stone disease. BJU Int. 2012;109:1082\u20137.","journal-title":"BJU Int"},{"key":"4326_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.eururo.2014.06.036","volume":"66","author":"JA Antonelli","year":"2014","unstructured":"Antonelli JA, Maalouf NM, Pearle MS, Lotan Y. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 2014;66:724\u20139.","journal-title":"Eur Urol"},{"key":"4326_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1089\/end.2004.18.534","volume":"18","author":"A Burgher","year":"2004","unstructured":"Burgher A, Beman M, Holtzman JL, Monga M. Progression of nephrolithiasis: long-term outcomes with observation of asymptomatic calculi. J Endourol. 2004;18:534\u20139.","journal-title":"J Endourol"},{"key":"4326_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0022-5347(17)37225-7","volume":"147","author":"LS Glowacki","year":"1992","unstructured":"Glowacki LS, Beecroft ML, Cook RJ, Pahl D, Churchill DN. The natural history of asymptomatic urolithiasis. J Urol. 1992;147:319\u201321.","journal-title":"J Urol"},{"key":"4326_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.eururo.2005.01.005","volume":"47","author":"MM Osman","year":"2005","unstructured":"Osman MM, Alfano Y, Kamp S, Haecker A, Alken P, Michel MS, et al. 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol. 2005;47:860\u20134.","journal-title":"Eur Urol"},{"key":"4326_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(01)05782-8","volume":"358","author":"G Bihl","year":"2001","unstructured":"Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management. Lancet. 2001;358:651\u20136.","journal-title":"Lancet"},{"key":"4326_CR9","unstructured":"Hospital episode statistics, admitted patient care, England 2013\u20132014. 2014. Available from: http:\/\/www.hscic.gov.uk\/catalogue\/PUB16719\/hosp-epis-stat-admi-proc-2013-14-tab.xlsx. Accessed Sept 2015."},{"key":"4326_CR10","doi-asserted-by":"crossref","unstructured":"Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M, et al. Guidelines on urolithiasis [document on the Internet]. Eur Assoc Urol. 2006. https:\/\/doi.org\/uroweb.org\/wp-content\/uploads\/Tiselius-et-al.-Eur-Urol-2001-40-362-37.Guidelines-on-Urolithiasis.pdf.","DOI":"10.1159\/000049803"},{"key":"4326_CR11","unstructured":"Turk C, Knoll T, Petrik A, Sarica K, Skolarikos A, Straub M, et al. Guidelines on urolithiasis. Arnhem: European Association of Urology; 2014. Available from: https:\/\/doi.org\/uroweb.org\/guideline\/urolithiasis. Accessed Sept 2015."},{"key":"4326_CR12","doi-asserted-by":"publisher","unstructured":"Srisubat A, Potisat S, Lojanapiwat B, Setthawong V, Laopaiboon M. Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones. Cochrane Database Syst Rev. 2014;(11):CD007044. https:\/\/doi.org\/10.1002\/14651858.CD007044.pub3.","DOI":"10.1002\/14651858.CD007044.pub3"},{"key":"4326_CR13","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0022-5347(05)65508-5","volume":"166","author":"DM Albala","year":"2001","unstructured":"Albala DM, Assimos DG, Clayman RV, Denstedt JD, Grasso M, Gutierrez-Aceves J, et al. Lower pole I: a prospective randomized trial of extracorporeal shock wave lithotripsy and percutaneous nephrostolithotomy for lower pole nephrolithiasis \u2014 initial results. J Urol. 2001;166:2072\u201380.","journal-title":"J Urol"},{"key":"4326_CR14","volume-title":"Stone disease: 1st International Consultation on Stone Disease","author":"P Alken","year":"2003","unstructured":"Alken P, Bellman G, Flam T, Fuchs GJ, Galluci M, Gaultier JR. Treatment of renal stone. In: Segura J, Conort P, Khoury S, Pak C, Preminger GM, Tolley D, editors. Stone disease: 1st International Consultation on Stone Disease. Paris: Health Publications; 2003.."},{"key":"4326_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000020093","volume":"37","author":"C Candau","year":"2000","unstructured":"Candau C, Saussine C, Lang H, Roy C, Faure F, Jacqmin D. Natural history of residual renal stone fragments after ESWL. Eur Urol. 2000;37:18\u201322.","journal-title":"Eur Urol"},{"key":"4326_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/end.1996.10.17","volume":"10","author":"AS Cass","year":"1996","unstructured":"Cass AS. Extracorporeal shockwave lithotripsy or percutaneous nephrolithotomy for lower pole nephrolithiasis? J Endourol. 1996;10:17\u201320.","journal-title":"J Endourol"},{"key":"4326_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1159\/000019623","volume":"33","author":"D Havel","year":"1998","unstructured":"Havel D, Saussine C, Fath C, Lang H, Faure F, Jacqmin D. Single stones of the lower pole of the kidney. Comparative results of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. Eur Urol. 1998;33:396\u2013400.","journal-title":"Eur Urol"},{"key":"4326_CR18","volume-title":"Campbell-Walsh urology","author":"MS Pearle","year":"2007","unstructured":"Pearle MS, Lotan Y. Urinary lithiasis: etiology, epidemiology, and pathogenesis. In: Campbell MF, Wein AJ, Kavoussi LR, editors. Campbell-Walsh urology. Philadelphia: W.B. Saunders; 2007."},{"key":"4326_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1089\/089277901753205852","volume":"15","author":"BK Auge","year":"2001","unstructured":"Auge BK, Dahm P, Wu NZ, Preminger GM. Ureteroscopic management of lower-pole renal calculi: technique of calculus displacement. J Endourol. 2001;15:835\u20138.","journal-title":"J Endourol"},{"key":"4326_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/end.2006.20.761","volume":"20","author":"SY Chung","year":"2006","unstructured":"Chung SY, Chon CH, Ng CS, Fuchs GJ. Simultaneous bilateral retrograde intrarenal surgery for stone disease in patients with significant comorbidities. J Endourol. 2006;20:761\u20135.","journal-title":"J Endourol"},{"key":"4326_CR21","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/S0022-5347(05)68065-2","volume":"162","author":"M Grasso","year":"1999","unstructured":"Grasso M, Ficazzola M. Retrograde ureteropyeloscopy for lower pole caliceal calculi. J Urol. 1999;162:1904\u20138.","journal-title":"J Urol"},{"key":"4326_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1089\/end.2006.20.556","volume":"20","author":"R Holland","year":"2006","unstructured":"Holland R, Margel D, Livne PM, Lask DM, Lifshitz DA. Retrograde intrarenal surgery as second-line therapy yields a lower success rate. J Endourol. 2006;20:556\u20139.","journal-title":"J Endourol"},{"key":"4326_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0090-4295(00)00821-9","volume":"56","author":"J Kourambas","year":"2000","unstructured":"Kourambas J, Delvecchio FC, Munver R, Preminger GM. Nitinol stone retrieval-assisted ureteroscopic management of lower pole renal calculi. Urology. 2000;56:935\u20139.","journal-title":"Urology"},{"key":"4326_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00240-005-0020-6","volume":"34","author":"GM Preminger","year":"2006","unstructured":"Preminger GM. Management of lower pole renal calculi: shock wave lithotripsy versus percutaneous nephrolithotomy versus flexible ureteroscopy. Urol Res. 2006;34:108\u201311.","journal-title":"Urol Res"},{"key":"4326_CR25","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1097\/01.ju.0000096421.56225.79","volume":"170","author":"K Stav","year":"2003","unstructured":"Stav K, Cooper A, Zisman A, Leibovici D, Lindner A, Siegel YI. Retrograde intrarenal lithotripsy outcome after failure of shock wave lithotripsy. J Urol. 2003;170:2198\u2013201.","journal-title":"J Urol"},{"key":"4326_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.juro.2009.12.022","volume":"183","author":"E Yuruk","year":"2010","unstructured":"Yuruk E, Binbay M, Sari E, Akman T, Altinyay E, Baykal M, et al. A prospective, randomized trial of management for asymptomatic lower pole calculi. J Urol. 2010;183:1424\u20138.","journal-title":"J Urol"},{"key":"4326_CR27","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1097\/01.ju.0000158458.51706.56","volume":"173","author":"MS Pearle","year":"2005","unstructured":"Pearle MS, Lingeman JE, Leveillee R, Kuo R, Preminger GM, Nadler RB, et al. Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol. 2005;173:2005\u20139.","journal-title":"J Urol"},{"key":"4326_CR28","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.eururo.2014.09.054","volume":"67","author":"JF Donaldson","year":"2015","unstructured":"Donaldson JF, Lardas M, Scrimgeour D, Stewart F, Maclennan S, Lam TBL, et al. Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy for lower-pole renal stones. Eur Urol. 2015;67:612\u20136.","journal-title":"Eur Urol"},{"issue":"Suppl","key":"4326_CR29","first-page":"e750","volume":"189","author":"A Kumar","year":"2013","unstructured":"Kumar A, Nanda B, Kumar N. A prospective randomized comparison between shock wave lithotripsy and flexible ureterorenoscopy lower calcyeal stones less than 2cm: a single center experience. J Urol. 2013;189(Suppl):e750.","journal-title":"J Urol"},{"key":"4326_CR30","unstructured":"Kuo RL, Lingeman JE, Leveillee RJ, Pearle MS, Watkins S, Fineberg NS, et al. Lower pole II: initial results from a comparison of shock wave lithotripsy (SWL), ureteroscopy (URS), and percutaneous nephrostolithotomy (PNL) for lower pole nephrolithiasis. J Urol. 2003;169(Suppl):486."},{"issue":"Suppl","key":"4326_CR31","first-page":"e751","volume":"189","author":"A Salem","year":"2013","unstructured":"Salem A, Saad I, Emran A, Abdelhakiem M, Abdelrazzak O, Abdelkader M. Laser lithotripsy versus ESWL for lower calyceal renal stones. J Urol. 2013;189(Suppl):e751.","journal-title":"J Urol"},{"key":"4326_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00240-013-0618-z","volume":"42","author":"NC Sener","year":"2014","unstructured":"Sener NC, Abdurrahim Imamoglu M, Bas O, Ozturk U, Goksel Goktug HN, Tuygun C, et al. Prospective randomized trial comparing shock wave lithotripsy and flexible ureterorenoscopy for lower pole stones smaller than 1 cm. Urolithiasis. 2014;42:127\u201331.","journal-title":"Urolithiasis"},{"key":"4326_CR33","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.urology.2013.12.026","volume":"83","author":"BP Singh","year":"2014","unstructured":"Singh BP, Prakash J, Sankhwar SN, Dhakad U, Sankhwar PL, Goel A, et al. Retrograde intrarenal surgery vs extracorporeal shock wave lithotripsy for intermediate size inferior pole calculi: a prospective assessment of objective and subjective outcomes. Urology. 2014;83:1016\u201322.","journal-title":"Urology"},{"key":"4326_CR34","doi-asserted-by":"crossref","unstructured":"Ragab M, Baldin N, Collie J, Tran M, Al-Hayek S, Parsy K, Armitage J, Wiseman O. Qualitative exploration of the renal stone patients\u2019 experience and development of the renal stone-specific patient-reported outcome measure. BJU Int. 2019. https:\/\/doi.org\/bjui-journal.onlinelibrary.wiley.com\/doi\/full\/10.1111\/bju.14873. Accessed 02 Sept 2019.","DOI":"10.1111\/bju.14873"},{"key":"4326_CR35","volume-title":"Economic evaluation in clinical trials","author":"HA Glick","year":"2007","unstructured":"Glick HA. Economic evaluation in clinical trials. Oxford: Oxford University Press; 2007."},{"key":"4326_CR36","doi-asserted-by":"publisher","first-page":"d1548","DOI":"10.1136\/bmj.d1548","volume":"342","author":"S Petrou","year":"2011","unstructured":"Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011;342:d1548.","journal-title":"BMJ"},{"key":"4326_CR37","doi-asserted-by":"publisher","first-page":"d1766","DOI":"10.1136\/bmj.d1766","volume":"342","author":"S Petrou","year":"2011","unstructured":"Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011;342:d1766.","journal-title":"BMJ"},{"key":"4326_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","volume":"15","author":"U Siebert","year":"2012","unstructured":"Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force 3. Value Health. 2012;15:812\u201320.","journal-title":"Value Health"},{"key":"4326_CR39","unstructured":"Guide to the methods of technology appraisal 2013. 2013. Available from: http:\/\/www.nice.org.uk\/article\/pmg9\/resources\/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf. Accessed Sept 2015."},{"key":"4326_CR40","unstructured":"NHS reference costs 2013\u201314 [website on the Internet]. London: Department of Health; 2014. Available from: https:\/\/www.gov.uk\/government\/publications\/nhs-reference-costs-2013-to-2014. Accessed Sept 2015."},{"key":"4326_CR41","unstructured":"Curtis L. Unit costs of health and social care 2014. 2014. Available from: http:\/\/www.pssru.ac.uk\/project-pages\/unit-costs\/2014\/. Accessed Sept 2015."},{"key":"4326_CR42","unstructured":"British national formulary. London: British Medical Association; 2014."},{"key":"4326_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hec.914","volume":"14","author":"A Manca","year":"2005","unstructured":"Manca A, Rice N, Sculpher MJ, Briggs AH. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ. 2005;14:471\u201385.","journal-title":"Health Econ"},{"key":"4326_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/hec.903","volume":"13","author":"E Fenwick","year":"2004","unstructured":"Fenwick E, O'Brien BJ, Briggs A. Cost-effectiveness acceptability curves \u2014 facts, fallacies and frequently asked questions. Health Econ. 2004;13:405\u201315.","journal-title":"Health Econ"},{"key":"4326_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V","volume":"9","author":"M Lothgren","year":"2000","unstructured":"Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ. 2000;9:623\u201330.","journal-title":"Health Econ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-04326-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04326-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:53:23Z","timestamp":1622764403000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04326-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4326"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04326-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"11 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Central ethical approval has been confirmed from the North of Scotland Research Ethics Committee (reference approval no. 15\/NS\/0113) and we will not begin recruiting at other centres in the trial until local ethical approval has been obtained. The trial will be conducted according to the principles of Good Clinical Practice provided by research governance guidelines. Informed consent will be obtained from all participants prior to any trial procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in this trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"479"}}